COCP
Cocrystal Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.13
+0.00%Next report
Analyst consensus
- Next report date
- Nov 13, 2026
- EPS estimate
- -$0.15
- Revenue estimate
- $105.0K
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.23
- EPS estimate
- -$0.17
- Revenue actual
- $105.0K
- Revenue estimate
- $105.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -6.7%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026